Every officer and director reconciles for this period.
External context: we only cite outside events when a documented connection exists. None is shown for this period.
What stands out
Eight insiders bought shares: Lawrence Culp Jr. (81K shares, $5.0M), Kevin Lobo (10K shares, $642K) and Peter Arduini (4.2K shares, $250K), plus 5 more.Lawrence Culp Jr.: purchase, May 6, 2026 · Kevin Lobo: purchase, May 22, 2026 · Peter Arduini: purchase, Apr 30, 2026
Tax withholding outweighed market sales: the company withheld $8.6M of officers' and directors' shares for taxes, against $0 sold on the open market. The largest was Peter Arduini ($4.2M withheld).Largest withholding, Feb 12, 2026
Percentages cover 21 of 23 officers and directors. Left out: Kevin Lobo and William Grogan (held no vested shares at the start). Disclosed company stock is not an insider's whole wealth.
Common questions
Is the GE HealthCare Technologies Inc. CEO selling stock?
No. Peter Arduini reported no open-market sales in the past 12 months.
Are any GE HealthCare Technologies Inc. insiders buying?
Yes. 8 officers or directors reported 8 purchases in the past 12 months (Form 4 code P, which includes private purchases).
The evidence
The full ownership picture23 of 23 insiders fully reconciled · 23 officers and directors
Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.
| Insider | Held Oct 8, 2025 | Sold | Held Oct 8, 2026 | Still held | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lawrence Culp Jr. Director | 411K | 0 | 500K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Lawrence Culp Jr.0shares vested or exercised 0gifted (net of own trusts) none reportedunvested awards, start → end | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Peter Arduini President and CEO, Director | 168K | 0 | 242K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Peter Arduini0shares vested or exercised 0gifted (net of own trusts) −54Kwithheld by the company for taxes none reportedunvested awards, start → end
Stock options (not counted as shares):
Estimate: options held × ($64.18 − strike price), using the most recent insider trade price on Form 4 (May 22, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Frank Jimenez GC & Corporate Secretary | 68K | 0 | 89K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Frank Jimenez0shares vested or exercised 0gifted (net of own trusts) −14Kwithheld by the company for taxes none reportedunvested awards, start → end
Stock options (not counted as shares):
Estimate: options held × ($64.18 − strike price), using the most recent insider trade price on Form 4 (May 22, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Taha Kass-Hout Chief Technology Officer | 65K | 0 | 88K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Taha Kass-Hout0shares vested or exercised 0gifted (net of own trusts) −13Kwithheld by the company for taxes none reportedunvested awards, start → end
Stock options (not counted as shares):
Estimate: options held × ($64.18 − strike price), using the most recent insider trade price on Form 4 (May 22, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| James Saccaro Chief Financial Officer | 59K | 0 | 87K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for James Saccaro0shares vested or exercised 0gifted (net of own trusts) −9.5Kwithheld by the company for taxes none reportedunvested awards, start → end
Stock options (not counted as shares):
Estimate: options held × ($64.18 − strike price), using the most recent insider trade price on Form 4 (May 22, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Kenneth Stacherski Chief Enterprise Oper. Officer | 41K | 0 | 41K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Kenneth Stacherski0shares vested or exercised 0gifted (net of own trusts) none reportedunvested awards, start → end
Stock options (not counted as shares):
Estimate: options held × ($64.18 − strike price), using the most recent insider trade price on Form 4 (May 22, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Jeannette Bankes CEO, Patient Care Solutions | 37K | 0 | 37K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Jeannette Bankes0shares vested or exercised 0gifted (net of own trusts) −6.6Kwithheld by the company for taxes none reportedunvested awards, start → end
Stock options (not counted as shares):
Estimate: options held × ($64.18 − strike price), using the most recent insider trade price on Form 4 (May 22, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roland Rott CEO, Imaging | 29K | 0 | 41K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Roland Rott0shares vested or exercised 0gifted (net of own trusts) −4.5Kwithheld by the company for taxes none reportedunvested awards, start → end
Stock options (not counted as shares):
Estimate: options held × ($64.18 − strike price), using the most recent insider trade price on Form 4 (May 22, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Catherine EstrampesiStarted reporting during the period; starting holdings are from the Form 3. Chief Commer. & Growth Officer | 24K | 0 | 24K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Catherine Estrampes0shares vested or exercised 0gifted (net of own trusts) −508withheld by the company for taxes none reportedunvested awards, start → end
Stock options (not counted as shares):
Estimate: options held × ($64.18 − strike price), using the most recent insider trade price on Form 4 (May 22, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Kevin O'Neill CEO, PDx | 23K | 0 | 32K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Kevin O'Neill0shares vested or exercised 0gifted (net of own trusts) −4.4Kwithheld by the company for taxes none reportedunvested awards, start → end
Stock options (not counted as shares):
Estimate: options held × ($64.18 − strike price), using the most recent insider trade price on Form 4 (May 22, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adam Holton Chief People Officer | 17K | 0 | 20K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Adam Holton0shares vested or exercised 0gifted (net of own trusts) −2.7Kwithheld by the company for taxes none reportedunvested awards, start → end
Stock options (not counted as shares):
Estimate: options held × ($64.18 − strike price), using the most recent insider trade price on Form 4 (May 22, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Philip Rackliffe CEO, Ais | 16K | 0 | 42K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Philip Rackliffe0shares vested or exercised 0gifted (net of own trusts) −3Kwithheld by the company for taxes none reportedunvested awards, start → end
Stock options (not counted as shares):
Estimate: options held × ($64.18 − strike price), using the most recent insider trade price on Form 4 (May 22, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| William Stromberg Director | 14K | 0 | 19K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
| Rodney Hochman Director | 14K | 0 | 22K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Rodney Hochman | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Anne Madden Director | 14K | 0 | 19K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
| Risa Lavizzo-Mourey Director | 10K | 0 | 10K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
| Catherine Lesjak Director | 9.1K | 0 | 13K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
| Lloyd Howell Jr. Director | 9.1K | 0 | 9.1K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
| Tomislav Mihaljevic Director | 9.1K | 0 | 9.1K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
| Watkin Yang Director | 9.1K | 0 | 14K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
George NewcombiAdditional holdings last reported more than 3 years ago are shown separately and excluded from totals. Chief Accounting Officer | 7.7K | 0 | 11K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for George Newcomb0shares vested or exercised 0gifted (net of own trusts) −1Kwithheld by the company for taxes none reportedunvested awards, start → end
Additional holdings last reported Jan 3, 2023, not confirmed since: 143 shares. Not included in any total or percentage on this page.
Stock options (not counted as shares):
Estimate: options held × ($64.18 − strike price), using the most recent insider trade price on Form 4 (May 22, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Kevin Lobo Director | 0 | 0 | 14K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Kevin Lobo0shares vested or exercised 0gifted (net of own trusts) none reportedunvested awards, start → end
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| William Grogan Chief Financial Officer | 0 | 0 | 75K | no sales | ||||||||||||||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for William Grogan0shares vested or exercised 0gifted (net of own trusts) none reportedunvested awards, start → end
Stock options (not counted as shares):
Estimate: options held × ($64.18 − strike price), using the most recent insider trade price on Form 4 (May 22, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
23 of 23 insiders fully reconciled: starting holdings plus reported transactions match ending holdings (23 exactly, 0 with a minor or footnoted difference). Percentages cover 21 of 23 officers and directors. Left out: Kevin Lobo and William Grogan (held no vested shares at the start). "Still held" compares ending with starting vested shares; a plus sign means the holding grew.
Is this normal? Selling year by yearNot enough history to compare
Not enough history to compare: fewer than three earlier years of filings.
| 12 months ending | Shares sold | Insiders who sold | Proceeds |
|---|---|---|---|
| Oct 8, 2026 Latest 12 months | 0 | 0 | $0 |
| Oct 8, 2025 1 year earlier | 6.5K | 3 | $573K |
| Oct 8, 2024 2 years earlier | 112K | 4 | $9.2M |
| Oct 9, 2023 3 years earlier · filings don't cover the whole year | 89K | 3 | $6.9M |
| Oct 9, 2022 4 years earlier · filings don't cover the whole year | n/a | n/a | n/a |
| Oct 9, 2021 5 years earlier · filings don't cover the whole year | n/a | n/a | n/a |
Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.
Known gaps and uncertaintyEvery officer and director reconciles
Sources and methodology254 filings from SEC EDGAR, and how we read them
All 254 Forms 3, 4 and 5 filed for GE HealthCare Technologies Inc. (SEC CIK 1932393) from Dec 8, 2022 to Sep 16, 2026, retrieved from SEC EDGAR on Oct 8, 2026. Prices are the ones reported in each filing, often weighted averages.
Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.
Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".
Former or inactive filers (7)No filing in 18 months; last reported balances, not in any total
| Name | Last filed | Last reported balance |
|---|---|---|
| Thomas Westrick | Mar 5, 2025 | 18,501 shares, last reported balance as of Mar 3, 2025 |
| Jan Makela | May 15, 2024 | 63,348 shares, last reported balance as of May 15, 2024 |
| GENERAL ELECTRIC CO | Mar 15, 2024 | 32,631,402 shares, last reported balance as of Mar 15, 2024 |
| Betty Larson | Mar 5, 2024 | 50,936 shares, last reported balance as of Mar 1, 2024 |
| Helmut Zodl | Dec 29, 2023 | 53,009 shares, last reported balance as of Apr 1, 2023 |
| Robert Giglietti | No balance on record | |
| Michael Holston | No balance on record |